Clinical Trial Challenges: FDA Wants More Prospective Studies, Validated Biomarkers

 
• By Brenda Sandburg
  
NIH Director Francis Collins and FDA Commissioner Robert Califf.
• Source: Photo by Brenda Sandburg

More from Clinical Trials

More from R&D